The rapid pace of change in life sciences is steadily increasing. Industry professionals are challenged with navigating the ever-evolving data requirements, regulations, technology upgrades and organizational landscapes. Our professionals partner with clients and offer value- based solutions, optimized business strategies and adaptive skills for long-term sustainability.
Insights for the Life Sciences Sector
Transformation and the future of life sciences.
Our latest thinking related to Life Sciences
No results found.
Insight
Building a cyber-resilient life sciences organization
Future-ready life sciences companies are developing broader cybersecurity oversight to help maintain resilience to new threats.
Insight
Life Sciences Winter CPE Webcast
Join KPMG's Life Sciences CPE session to hear from experts on financial reporting concerns and industry trends in a 2-hour session.
Insight
Empowering life sciences through organizational learning
Unlocking the future of life sciences with KPMG
Insight
The CIO’s Pivotal Guide to Navigating the MedTech Landscape
In an increasingly competitive MedTech landscape, CIOs play a crucial role in addressing supply and demand, digital equity, interoperability, cybersecurity, data privacy, and AI-driven transformation.
Insight
MedTech: Reshaping healthcare delivery
A new KPMG paper explores how the MedTech industry is poised to redefine patient and provider experiences with innovative technologies.
Insight
Latest Trends in M&A and Alternative Deal Structures in the Biopharma Market
Life sciences tax webcast
Insight
Transforming at the core
Life sciences industry taps managed services for core operations
Insight
Practical ESG considerations for life science companies of all sizes
KPMG Life Sciences Webcast
Insight
Life Sciences CPE Session
In this webcast, KPMG subject matter professionals address financial reporting concerns, how to mitigate audit risk, and specific trends in the life sciences industry.
Insight
Emerging biotechnology webcast series
Welcome to the KPMG 2023 Emerging Biopharma webcast series. This webcast series is being provided to our life sciences organizations throughout the year in efforts to help them navigate the current environment.
Insight
Pharma leaders collaborate on supply-chain security framework
KPMG spearheaded a cross-institutional team of pharma supply-chain leaders to develop a proprietary cybersecurity framework.
Insight
Artificial intelligence across the biopharma landscape
An overview of key trends that demonstrate AI’s staying power in the biopharma industry
Insight
New trends in life sciences sales strategies
Insights from recent KPMG life science sales leader research
Insight
The key levers for ROI and revenue growth
Insights from recent KPMG life science sales leader research
Insight
Maximizing the Benefits of IT/OT Convergence in Pharma Life Sciences Manufacturing: Solutions to Common Challenges
Insight
People bring digital transformation to life.
Make the people and technology changes needed, to unlock value in the new digital life sciences economy.
Insight
Artificial intelligence and its expanding role across the biopharma landscape
AI and its expanding role across the biopharma landscape
Insight
From theory to practice
Adopting Computer Software Assurance for today’s technologies in life sciences
Insight
Jaguar Gene Therapy
Join me as Sukumar Nagendran, President of R&D at Jaguar Gene Therapies shares his unique experience and insights around the development and launch of one-and-done gene therapies.
Insight
Poseida Therapeutics
Join me as I interview Eric Ostertag, CEO of Poseida therapeutics, as we discuss the innovative approaches that Poseida is taking to the manufacturing and delivery challenges in gene therapy.
Insight
6 ways to accelerate your pharma sales model
How pharmaceutical sales models impact revenue growth
Insight
Sick Cells and RedMoon Advocacy groups
Join me as I interview the warriors from Sick Cells and RedMoon Project, Ashley Valentine, Adrienne Shapiro and Corey Lewis as they talk about how racial inequality has affected the sickle cell community.
Insight
CureDuchenne
Join me as I interview Debra Miller, co-founder and CEO of CureDuchenne as she talks about the impact that the disease has on the entire family unit, on the Duchenne’s community, the critical role that CureDuchenne is playing in supporting research.
Insight
Vineti
Join me as I speak with Amy DuRoss, CEO and co-founder of Vineti, as she talks about some of the innovation she’s seeing across the manufacturing and supply chain.
Insight
Dealmaking still a key to growth: Q3’23 M&A trends in life sciences
Even with continued uncertainty in the US economy, the data suggests that life sciences M&As could pick up in 2024.
Insight
2023 KPMG US Life Sciences Sector Insights Report
Life sciences companies are sophisticated business organizations with high levels of scientific knowledge. But many are still striving to ensure that the technology supporting their back office measures up to the same high standards set in their research laboratories.
Insight
Supply chain considerations for M&A transactions
Future of Life Sciences Supply Chain: second issue
Insight
Blog 2: Digital twin landscape and getting started
The digital twin enables powerful capabilities for life science companies.
Insight
Blog 1: Life Sciences Medical Device Digital Transformation
Mega-Process Intelligent Automation (IA) Strategy & Implementation Services
Insight
Blog 4: Digital Twins for Life Science
Understanding how digital twins work and how this technology is being used within life sciences organizations
Insight
Life Sciences Operations
Improving our clients Regulatory, Quality, & Operations functions, addressing business needs with process transformation and technology enablement
Insight
KPMG life sciences technology insights report
KPMG reports on the state of life sciences industry digital transformation, automation, artificial intelligence, and machine learning
Insight
FCPA and anti-corruption strategies for the life sciences industry
Mini-Roundtable
Insight
Life Sciences in a Time of Stress
Optimizing enterprise data is key to precision medicine. It also helps address other industry challenges tied to cost and complexity. Here's how.
Insight
The future of life sciences is connected, AI-driven, and patient-centric
The future of life sciences will likely be shaped by tech-enabled connectivity, strategic uses of AI, and patient-centric supply chains.
Insight
KPMG CFO life sciences roundtable first edition
Trends and insights from industry leaders
Insight
Biopharma deal trends outlook for 2023: Q3’22 M&A trends in lifesciences
Near-term headwinds, with possible run on small biotechs on the horizon
Insight
Digital Transformation and R&D in the Pharmaceutical Industry
This webcast will discuss digital transformation and R&D in the pharmaceutical industry. Topics include the current state of digital transformation and R&D, impact on the industry value chain, and tax and transfer pricing implications.
Insight
Turn your carbon emissions data into a strategic asset
Why financial services companies should integrate carbon emissions data into the finance information landscape.
Insight
Transfer Pricing Considerations in the Age of Precision Medicine
Disruption caused by chimeric antigen receptor T-cell (CAR T) therapy, a type of cell and gene therapy, to exploring standard business models in the life sciences industry.
Insight
Medtech’s top 5 challenges from legacy sales models
Now is the time to evolve your sales model
Insight
Life Sciences: KPMG 2022 Fraud Outlook
A triple threat across the Americas
Insight
FCPA and anti-corruption strategies for the life sciences industry
Mini-Roundtable
Insight
6 ways to accelerate your Medtech sales model
Now is the time to evolve your sales model.
Insight
“One-and-done” gene therapies
A near-term niche?
Insight
Life Sciences: KPMG 2022 Fraud Outlook
A triple threat across the Americas
Insight
Inflation Reduction Act: Part D Benefit Reforms: Impacts on Pharmaceutical Manufacturers, Plans, and Patients
Part D Changes Likely to Impact Stakeholder Financial Incentives and Behavior
Insight
Health Equity
Doing good and doing well in life sciences
Insight
Blog 5:Getting the Edge
Key insights on how to approach Technology risks in Life Sciences and which are worth taking.
Insight
Life Sciences: ESG Tax Incentives and Related Hot Topics
KPMG Life Sciences Webcast
